Longitude Capital — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants.
BiotechDigital HealthFemTechHealthtechWellness & FitnessSacramento, US
J. Bruce German(Co-founder)David Mills(Co-founder)Carlito Lebrilla(Co-founder)Daniela Barile(Co-founder)Samara Freeman(Co-founder & Director of Intellectual Property and Regulatory Affairs)Michael Johnson(Executive Officer, Director)
Co-investorsAcre Venture PartnersBow CapitalHorizons VenturesiSelect FundBill & Melinda Gates FoundationSpruce Capital Partners
BiotechSan Carlos, US
Surag Mantri(Executive Officer, Director)
BoardJustin Klein(Director)inMatthew Sprinkel(Director)Amir Abolfathi(Director)Varun Gupta(Director)
Co-investorsBoutique Venture PartnersNeotribe VenturesVensana Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.